Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The structure of the antimicrobial human cathelicidin LL-37 shows oligomerization and channel formation in the presence of membrane mimics
Enea Sancho‐Vaello, David Gil-Cartón, Patrice François, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Antimicrobial peptides: Opportunities and challenges in overcoming resistance
Cezara Bucataru, Corina Ciobănaşu
Microbiological Research (2024) Vol. 286, pp. 127822-127822
Open Access | Times Cited: 41
LL-37: Structures, Antimicrobial Activity, and Influence on Amyloid-Related Diseases
Surajit Bhattacharjya, Zhizhuo Zhang, Ayyalusamy Ramamoorthy
Biomolecules (2024) Vol. 14, Iss. 3, pp. 320-320
Open Access | Times Cited: 24
Plant-Derived Polyphenol and LL-37 Peptide-Modified Nanofibrous Scaffolds for Promotion of Antibacterial Activity, Anti-Inflammation, and Type-H Vascularized Bone Regeneration
Shue Jin, Renli Yang, Chen Hu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 6, pp. 7804-7820
Closed Access | Times Cited: 30
Structure-based mechanisms of 2′3′-cGAMP intercellular transport in the cGAS–STING immune pathway
Wei Xie, Dinshaw J. Patel
Trends in Immunology (2023) Vol. 44, Iss. 6, pp. 450-467
Closed Access | Times Cited: 22
cGAMP the travelling messenger
Henry T.W. Blest, Lise Chauveau
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
Cathelicidin LL-37 in Health and Diseases of the Oral Cavity
Joanna Tokajuk, Piotr Deptuła, Ewelina Piktel, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1086-1086
Open Access | Times Cited: 35
Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis
Karim M. Aloul, Josefine Eilsø Nielsen, Erwin B. Defensor, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Characterization of inositol lipid metabolism in gut-associated Bacteroidetes
Stacey L. Heaver, Henry H. Le, Peijun Tang, et al.
Nature Microbiology (2022) Vol. 7, Iss. 7, pp. 986-1000
Open Access | Times Cited: 30
Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of Escherichia coli and Pseudomonas aeruginosa
Kylen E. Ridyard, Mariam Elsawy, Destina Mattrasingh, et al.
Antibiotics (2023) Vol. 12, Iss. 2, pp. 389-389
Open Access | Times Cited: 18
High-resolution structural information of membrane-bound α-synuclein provides insight into the MoA of the anti-Parkinson drug UCB0599
Thomas C. Schwarz, Andreas Beier, Karin Ledolter, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 15
Open Access | Times Cited: 16
No country for old antibiotics! Antimicrobial peptides (AMPs) as next-generation treatment for skin and soft tissue infection
Mina Răileanu, Raluca Borlan, Andreea Campu, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123169-123169
Closed Access | Times Cited: 16
Recent advances in the therapeutic potential of cathelicidins
Maria Eduarda Souza Guerra, Brenda Vieira, Ana Paula Carvalho Thiers Calazans, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Structure of the Bacterial Cell Envelope and Interactions with Antimicrobials: Insights from Molecular Dynamics Simulations
Pradyumn Sharma, Rakesh Vaiwala, Amar Krishna Gopinath, et al.
Langmuir (2024) Vol. 40, Iss. 15, pp. 7791-7811
Closed Access | Times Cited: 6
Comparative Study of Vitamin D Levels in Newly Diagnosed Tuberculosis and a Normal Population
Vasanth Kumar Mamadapur, Shreesha Nagaraju, Mukhyaprana Prabhu
Medicina (2024) Vol. 60, Iss. 5, pp. 685-685
Open Access | Times Cited: 6
Unveiling Mechanisms of Antimicrobial Peptide: Actions Beyond the Membranes Disruption
K R Gagandeep, Ramesh B. Narasingappa, Gatta Vishnu Vyas
Heliyon (2024) Vol. 10, Iss. 19, pp. e38079-e38079
Open Access | Times Cited: 6
Impact of Vitamin D in Prophylaxis and Treatment in Tuberculosis Patients
Roberta Papagni, Carmen Pellegrino, Francesco Di Gennaro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3860-3860
Open Access | Times Cited: 27
Multiple Antimicrobial Effects of Hybrid Peptides Synthesized Based on the Sequence of Ribosomal S1 Protein from Staphylococcus aureus
Sergey V. Kravchenko, Pavel A. Domnin, Sergei Y. Grishin, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 524-524
Open Access | Times Cited: 23
Protein Oligomer Engineering: A New Frontier for Studying Protein Structure, Function, and Toxicity
Chang Liu, Jinghui Luo
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 23
Open Access | Times Cited: 15
Oral microbiota and metabolites: key players in oral health and disorder, and microbiota-based therapies
Narjess Bostanghadiri, Mobina Kouhzad, Elahe Taki, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Dissecting the relationship between antimicrobial peptides and mesenchymal stem cells
Amandda Évelin Silva-Carvalho, Marlon H. Cardoso, Thuany Alencar‐Silva, et al.
Pharmacology & Therapeutics (2021) Vol. 233, pp. 108021-108021
Closed Access | Times Cited: 29
Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant Staphylococcus aureus Strains: Classification, Structures, and Mechanisms of Action
Isabella Hernández-Aristizábal, Iván Darío Ocampo-Ibáñez
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 7927-7927
Open Access | Times Cited: 27
Alternative Antibiotics in Dentistry: Antimicrobial Peptides
Alexandra Griffith, Akilah I. Mateen, Kenneth Markowitz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1679-1679
Open Access | Times Cited: 21
LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosis
Marko Radic, Sylviane Muller
Cells (2022) Vol. 11, Iss. 15, pp. 2463-2463
Open Access | Times Cited: 19
Origami of KR-12 Designed Antimicrobial Peptides and Their Potential Applications
Jayaram Lakshmaiah Narayana, Abraham Fikru Mechesso, Imran Rather, et al.
Antibiotics (2024) Vol. 13, Iss. 9, pp. 816-816
Open Access | Times Cited: 4
Knowledge mapping and research trends of cathelicidin peptide LL-37 from 1995 to 2024: a bibliometric study
Hongxin Shi, P. SHU, Zhi-Hao Wang, et al.
Computer Methods in Biomechanics & Biomedical Engineering (2025), pp. 1-14
Closed Access
Page 1 - Next Page

Scroll to top